ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 889

Identification of Genetic Variants Associated with Erosive Hand Osteoarthritis Using Pedigrees from a State-Wide Population-Based Cohort

Nikolas Kazmers1, Kendra Novak 1, Zhe Yu 2, Tyler Barker 3, Tyler Abraham 4, Robin Romero 4 and Michael Jurynec 1, 1University of Utah, Department of Orthopaedics, Salt Lake City, UT, 2Huntsman Cancer Institute - Utah Population Database Resource, Salt Lake City, UT, 3Intermountain Healthcare, Precision Genomics, Murray, UT, 4Intermountain Healthcare, Precision Genomics, St. George, UT

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Cogalt1, Erosive osteoarthritis, Genetic, Hand Osteoarthritis and Pathopysiology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: 3S105: Osteoarthritis & Joint Biology – Basic Science (886–891)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Erosive osteoarthritis (EOA) of the hand is a characterized radiographically with centrally-located interphalangeal joint erosions, and clinically by its rapid onset, rapid rate of progression, and potential for substantial disability and deformity.  Although an association between a single nucleotide polymorphism in the interleukin-1β gene has been demonstrated for EOA in a small case-control study, it remains unclear whether this condition has a genetic basis and there remains a lack of understanding of the underlying pathophysiology. Our purpose was to determine whether EOA clusters in families, which would suggest a genetic etiologic contribution.  Secondarily, we performed genomic analyses on one high-risk family with EOA to identify candidate genes that have a significant contribution to the onset and progression of EOA.

Methods: EOA patients were identified by ICD-10 code (M15.4), then mapped to pedigrees using methods developed by the Utah Population Database (UPDB).   The UPDB is a collection of >10 million individuals in multigenerational pedigrees dating back to the late 1700’s which are linked to >30 million medical records.  High-risk families with excess clustering of EOA were identified using the Familial Standardized Incidence Ratio (FSIR) threshold of ≥ 2.0. The magnitude of familial risk was calculated using relative risk from Cox regression models to determine the relative risk of EOA in related individuals using a ratio of 1:10 affected individuals to controls.  Genomic analyses were performed as previously reported.

Results: We identified 231 unrelated high-risk pedigrees with an FSIR ≥ 2.0 (top pedigrees illustrated in Table 1).  Of the 580 affected individuals within these pedigrees, mean age at diagnosis was 66 ± 11.0 years and 80.1% were female. The relative risk of developing EOA was significantly elevated in first-degree relatives (RR 30.51; 95% confidence interval 3.3 – 282.4; p = 0.0026).  Genomic analyses in one EOA family consisting of two distantly related affected individuals and one unaffected sibling (Figure 1) identified a rare coding variant in the procollagen galactosyltransferase COLGALT1 (Arg326Cys, AF – 0.00009)  (Figure 2).

Conclusion: Our finding of excess familial clustering of hand EOA patients indicates a significant genetic contribution to the etiology of the disease.  Although functional testing is still underway, we have identified a coding  variant associated with EOA – namely COLGALT1, a gene involved with glycosylation of hydroxylated lysines in procollagen.6  These results, and those to be gained through whole-exome sequencing of additional identified high-risk pedigrees, may lead to an improved understanding of EOA pathophysiology.

Figure 1

Figure 2

Figure 3


Disclosure: N. Kazmers, None; K. Novak, None; Z. Yu, None; T. Barker, None; T. Abraham, None; R. Romero, None; M. Jurynec, None.

To cite this abstract in AMA style:

Kazmers N, Novak K, Yu Z, Barker T, Abraham T, Romero R, Jurynec M. Identification of Genetic Variants Associated with Erosive Hand Osteoarthritis Using Pedigrees from a State-Wide Population-Based Cohort [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/identification-of-genetic-variants-associated-with-erosive-hand-osteoarthritis-using-pedigrees-from-a-state-wide-population-based-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-genetic-variants-associated-with-erosive-hand-osteoarthritis-using-pedigrees-from-a-state-wide-population-based-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology